News & Updates

MRI scoring systems accurately assess cognitive, motor development in infants

13 Jan 2022

Existing scoring systems for magnetic resonance imaging (MRI) scans are sufficiently predictive of cognitive and motor outcomes in term-born infants, a recent study has found. For language assessment, more detailed scoring inventories seem to perform better.

MRI scoring systems accurately assess cognitive, motor development in infants

13 Jan 2022

Miscarriage, stillbirth tied to heightened stroke risk among women

13 Jan 2022

Women who have experienced miscarriage and stillbirth are at higher risk of stroke, as suggested in a recent meta-analysis.

Miscarriage, stillbirth tied to heightened stroke risk among women

13 Jan 2022

Aneurysm plugging device proven safe, effective in real-world study

11 Jan 2022 by

A device for treating aneurysms or balloon-like swelling of blood vessels due to weakened artery walls has passed muster in real world, showing a favourable efficacy and safety profile, according to data from the WorldWideWEB Consortium.

Aneurysm plugging device proven safe, effective in real-world study

11 Jan 2022

Disease-modifying agents for multiple sclerosis do not elevate cancer risk

09 Jan 2022

Several disease-modifying therapies (DMTs) for multiple sclerosis (MS) do not pose an increased risk of cancer, a study has shown.

Disease-modifying agents for multiple sclerosis do not elevate cancer risk

09 Jan 2022

Prior stroke may influence ischaemic stroke risk in cancer patients

07 Jan 2022 by

Prior history of ischaemic stroke appears to affect the risk of ischaemic stroke in patients newly diagnosed with cancer, according to a study from Canada presented at ASH 2021.

Prior stroke may influence ischaemic stroke risk in cancer patients

07 Jan 2022

Apixaban vs rivaroxaban in AF: Is one better than the other?

06 Jan 2022 by

Rivaroxaban was associated with a greater risk of major ischaemic or haemorrhagic events compared with apixaban in elderly patients with atrial fibrillation (AF) — suggesting that apixaban appears to be preferable over rivaroxaban when considering oral anticoagulant choice in these patients, according to a retrospective cohort study.

Apixaban vs rivaroxaban in AF: Is one better than the other?

06 Jan 2022

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

06 Jan 2022

New drug applications approved by US FDA as of 16-31 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

06 Jan 2022

Stroke one of the strongest predictors of COVID-19 mortality

06 Jan 2022 by

A territory-wide retrospective cohort study by the Chinese University of Hong Kong (CUHK) has found that stroke is the third strongest predictor of coronavirus disease 2019 (COVID-19) mortality, after advancing age and renal disease, while Parkinson’s disease (PD) was the second strongest predictor of death after advancing age during the severe acute respiratory syndrome (SARS) epidemic of 2003.

Stroke one of the strongest predictors of COVID-19 mortality

06 Jan 2022

Functional electrical stimulation–assisted cycling training improves lower limb function in chronic stroke survivors

05 Jan 2022 by

A longitudinal pilot study by the Chinese University of Hong (CUHK) and Northwestern Polytechnical University in Xi’an, China, used electrical impedance myography (EIM) and surface electromyography (sEMG) to demonstrate that functional electrical stimulation (FES)–assisted cycling training improves lower limb function in chronic stroke survivors through increasing muscle impedance properties, improving muscle activation capacity, and allowing better muscle coordination during ankle joint movements.

Functional electrical stimulation–assisted cycling training improves lower limb function in chronic stroke survivors

05 Jan 2022

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

27 Dec 2021 by

A large retrospective study conducted in the US and Europe and presented at RSNA 2021 has suggested that central nervous system (CNS) complications may affect approximately one in 100 patients hospitalized with COVID-19.

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

27 Dec 2021

News & Updates

Filter by Specialty:

Specialty:

MRI scoring systems accurately assess cognitive, motor development in infants

MRI scoring systems accurately assess cognitive, motor development in infants

Miscarriage, stillbirth tied to heightened stroke risk among women

Miscarriage, stillbirth tied to heightened stroke risk among women

Aneurysm plugging device proven safe, effective in real-world study

Aneurysm plugging device proven safe, effective in real-world study

Disease-modifying agents for multiple sclerosis do not elevate cancer risk

Disease-modifying agents for multiple sclerosis do not elevate cancer risk

Prior stroke may influence ischaemic stroke risk in cancer patients

Prior stroke may influence ischaemic stroke risk in cancer patients

Apixaban vs rivaroxaban in AF: Is one better than the other?

Apixaban vs rivaroxaban in AF: Is one better than the other?

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

Original New Drug Application Approvals by US FDA (16 - 31 December 2021)

Stroke one of the strongest predictors of COVID-19 mortality

Stroke one of the strongest predictors of COVID-19 mortality

Functional electrical stimulation–assisted cycling training improves lower limb function in chronic stroke survivors

Functional electrical stimulation–assisted cycling training improves lower limb function in chronic stroke survivors

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

CNS complications in COVID-19: 1 in 100 hospitalized patients affected